Palisade Bio, Inc.
DE ˙ DB
SecurityDE:7NS0 / Palisade Bio, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership2,103,353 shares
Latest Disclosed Value $ 3,680,868
Millennium Management Llc reports 614.25% increase in ownership of 7NS0 / Palisade Bio, Inc.

On May 15, 2026 - Millennium Management Llc filed a 13F-HR form disclosing ownership of 2,103,353 shares of Palisade Bio, Inc. (DE:7NS0) valued at $3,680,868 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 294,486 shares of Palisade Bio, Inc.. This represents a change in shares of 614.25% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F PALISADE BIO COM 696389402 2,103,353 1,808,867 614.25 3,681 431.79 0.0015
2026-02-17 2025-12-31 13F PALISADE BIO COM 696389402 294,486 294,486 692 0.0003
2023-02-14 2022-12-31 13F PALISADE BIO COM 696389105 0 -68,338 -100.00 0 -100.00
2022-11-14 2022-09-30 13F PALISADE BIO COM 696389105 68,338 49,365 260.19 7 -12.50 0.0000
2022-08-15 2022-06-30 13F PALISADE BIO COM 696389105 18,973 18,973 8 0.0000
2016-08-15 2016-06-30 13F NEURALSTEM COM 64127R302 0 -244,042 -100.00 0 -100.00
2016-05-16 2016-03-31 13F NEURALSTEM COM 64127R302 244,042 -98,894 -28.84 183 -48.16 0.0005
2016-02-16 2015-12-31 13F NEURALSTEM COM 64127R302 342,936 -325,635 -48.71 353 -56.74 0.0007
2015-11-16 2015-09-30 13F NEURALSTEM COM 64127R302 668,571 -90,691 -11.94 816 -44.60 0.0016
2015-08-14 2015-06-30 13F NEURALSTEM COM 64127R302 759,262 759,262 0.00 1,473 0.0028
2014-11-14 2014-09-30 13F NEURALSTEM COM 64127R302 0 -280,399 -100.00 0 -100.00
2014-08-14 2014-06-30 13F NEURALSTEM COM 64127R302 280,399 261,108 1,353.52 1,183 1,360.49 0.0033
2014-05-15 2014-03-31 13F NEURALSTEM COM 64127R302 19,291 19,291 81 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.